Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio
Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for an undisclosed price. According to Sorrento Therapeutics, the acquisition is in response to drastic increasing demands around the world and planned product build-up expecting possible additional approvals for its COVISTIX Covid-19 virus rapid antigen detection test. Zhengzhou […]